Viewing Study NCT03432533


Ignite Creation Date: 2025-12-25 @ 3:03 AM
Ignite Modification Date: 2025-12-26 @ 1:43 AM
Study NCT ID: NCT03432533
Status: COMPLETED
Last Update Posted: 2020-11-23
First Post: 2018-01-30
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Comparison of Subject-administered Romosozumab With Healthcare Provider-administered Romosozumab for Osteoporosis
Sponsor: Amgen
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2018-02-06
Start Date Type: ACTUAL
Primary Completion Date: 2019-04-11
Primary Completion Date Type: ACTUAL
Completion Date: 2020-01-08
Completion Date Type: ACTUAL
First Submit Date: 2018-01-30
First Submit QC Date: None
Study First Post Date: 2018-02-14
Study First Post Date Type: ACTUAL
Results First Submit Date: 2020-03-24
Results First Submit QC Date: None
Results First Post Date: 2020-04-10
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-05
Last Update Post Date: 2020-11-23
Last Update Post Date Type: ACTUAL